Paxlovid Prescribing – Navigating Uncertainties
Gain valuable insights and practical knowledge on how to manage challenges and uncertainties when prescribing medication.
This is a recording of a live webinar held on December 21, 2022
This webinar will provide an up-to-date overview of the evidence for nirmatrelvir/ritonavir (Paxlovid) in the treatment of COVID-19 infection. It will explain the process for prescribing, discuss the assessment of the risk of progression to severe illness, the management of drug interactions. A panel of expert prescribers will discuss the nuances and challenges that prescribers face when prescribing medication.
This webinar is supported by an education grant from Pfizer Canada ULC